High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

Clinical trial NCT05011383 · RECRUITING

Trial details

NCT number: NCT05011383
Sponsor: VA Office of Research and Development
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2021-08-31
Primary completion: 2026-08-31
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.